These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 30150778)

  • 1. Distinct systemic microbiome and microbial translocation are associated with plasma level of anti-CD4 autoantibody in HIV infection.
    Xu W; Luo Z; Alekseyenko AV; Martin L; Wan Z; Ling B; Qin Z; Heath SL; Maas K; Cong X; Jiang W
    Sci Rep; 2018 Aug; 8(1):12863. PubMed ID: 30150778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of plasma auto-IgGs on CD4
    Luo Z; Zhou Z; Ogunrinde E; Zhang T; Li Z; Martin L; Wan Z; Wu H; Qin Z; Ou T; Zhang J; Ma L; Liao G; Heath S; Huang L; Jiang W
    J Leukoc Biol; 2017 Dec; 102(6):1481-1486. PubMed ID: 29030391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic translocation of Staphylococcus drives autoantibody production in HIV disease.
    Luo Z; Li M; Wu Y; Meng Z; Martin L; Zhang L; Ogunrinde E; Zhou Z; Qin S; Wan Z; Westerink MAJ; Warth S; Liu H; Jin P; Stroncek D; Li QZ; Wang E; Wu X; Heath SL; Li Z; Alekseyenko AV; Jiang W
    Microbiome; 2019 Feb; 7(1):25. PubMed ID: 30764863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy.
    Wallet MA; Rodriguez CA; Yin L; Saporta S; Chinratanapisit S; Hou W; Sleasman JW; Goodenow MM
    AIDS; 2010 Jun; 24(9):1281-90. PubMed ID: 20559035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic immune activation and microbial translocation in dual HIV/tuberculosis-infected subjects.
    Toossi Z; Funderburg NT; Sirdeshmuk S; Whalen CC; Nanteza MW; Johnson DF; Mayanja-Kizza H; Hirsch CS
    J Infect Dis; 2013 Jun; 207(12):1841-9. PubMed ID: 23479321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between different methods to measure microbial translocation and its association with immune activation in long-term suppressed HIV-1-infected individuals.
    Abad-Fernández M; Vallejo A; Hernández-Novoa B; Díaz L; Gutiérrez C; Madrid N; Muñoz MA; Moreno S
    J Acquir Immune Defic Syndr; 2013 Oct; 64(2):149-53. PubMed ID: 24047967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Link Between Plasma Microbial Translocation, Microbiome, and Autoantibody Development in First-Degree Relatives of Systemic Lupus Erythematosus Patients.
    Ogunrinde E; Zhou Z; Luo Z; Alekseyenko A; Li QZ; Macedo D; Kamen DL; Oates JC; Gilkeson GS; Jiang W
    Arthritis Rheumatol; 2019 Nov; 71(11):1858-1868. PubMed ID: 31106972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection.
    Mak G; Zaunders JJ; Bailey M; Seddiki N; Rogers G; Leong L; Phan TG; Kelleher AD; Koelsch KK; Boyd MA; Danta M
    Front Immunol; 2021; 12():688886. PubMed ID: 34135912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of gut-homing β7 receptor on T cells: surrogate marker for microbial translocation in suppressed HIV-1-infected patients?
    Abad-Fernández M; Gutiérrez C; Madrid N; Hernández-Novoa B; Díaz L; Muñoz-Fernández MA; Moreno S; Vallejo A
    HIV Med; 2015 Jan; 16(1):15-23. PubMed ID: 24831847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated Cerebrospinal Fluid Anti-CD4 Autoantibody Levels in HIV Associate with Neuroinflammation.
    Cheng D; Luo Z; Fu X; Stephenson S; Di Germanio C; Norris PJ; Fuchs D; Ndhlovu LC; Li QZ; Zetterberg H; Gisslen M; Price RW; Peng S; Jiang W
    Microbiol Spectr; 2022 Feb; 10(1):e0197521. PubMed ID: 34985329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug Use is Associated with Anti-CD4 IgG-mediated CD4+ T Cell Death and Poor CD4+ T Cell Recovery in Viral-suppressive HIV-infected Individuals Under Antiretroviral Therapy.
    Jiang W; Luo Z; Martin L; Wan Z; Fu P; Wagner A; Ling B; Heath SL; Haque A; McRae-Clark A
    Curr HIV Res; 2018; 16(2):143-150. PubMed ID: 29968539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reconstitution of intestinal CD4 and Th17 T cells in antiretroviral therapy suppressed HIV-infected subjects: implication for residual immune activation from the results of a clinical trial.
    d'Ettorre G; Baroncelli S; Micci L; Ceccarelli G; Andreotti M; Sharma P; Fanello G; Fiocca F; Cavallari EN; Giustini N; Mallano A; Galluzzo CM; Vella S; Mastroianni CM; Silvestri G; Paiardini M; Vullo V
    PLoS One; 2014; 9(10):e109791. PubMed ID: 25340778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B lymphocyte stimulator protein-associated increase in circulating autoantibody levels may require CD4+ T cells: lessons from HIV-infected patients.
    Stohl W; Cheema GS; Briggs WS; Xu D; Sosnovtseva S; Roschke V; Ferrara DE; Labat K; Sattler FR; Pierangeli SS; Hilbert DM
    Clin Immunol; 2002 Aug; 104(2):115-22. PubMed ID: 12165272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL13 as a Biomarker of Immune Activation During Early and Chronic HIV Infection.
    Mehraj V; Ramendra R; Isnard S; Dupuy FP; Lebouché B; Costiniuk C; Thomas R; Szabo J; Baril JG; Trottier B; Coté P; LeBlanc R; Durand M; Chartrand-Lefebvre C; Kema I; Zhang Y; Finkelman M; Tremblay C; Routy JP
    Front Immunol; 2019; 10():289. PubMed ID: 30846990
    [No Abstract]   [Full Text] [Related]  

  • 15. Gut microbiota diversity predicts immune status in HIV-1 infection.
    Nowak P; Troseid M; Avershina E; Barqasho B; Neogi U; Holm K; Hov JR; Noyan K; Vesterbacka J; Svärd J; Rudi K; Sönnerborg A
    AIDS; 2015 Nov; 29(18):2409-18. PubMed ID: 26355675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbial Translocation Is Linked to a Specific Immune Activation Profile in HIV-1-Infected Adults With Suppressed Viremia.
    Younas M; Psomas C; Reynes C; Cezar R; Kundura L; Portales P; Merle C; Atoui N; Fernandez C; Le Moing V; Barbuat C; Moranne O; Sotto A; Sabatier R; Fabbro P; Vincent T; Dunyach-Remy C; Winter A; Reynes J; Lavigne JP; Corbeau P
    Front Immunol; 2019; 10():2185. PubMed ID: 31572392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual HIV-specific CD4 and CD8 T cell frequencies after prolonged antiretroviral therapy reflect pretreatment plasma virus load.
    Oxenius A; Price DA; Dawson SJ; Günthard HF; Fischer M; Perrin L; Ramirez E; Fagard C; Hirschel B; Scullard G; Weber JN; McLean AR; Phillips RE;
    AIDS; 2002 Nov; 16(17):2317-22. PubMed ID: 12441804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut Lactobacillales are associated with higher CD4 and less microbial translocation during HIV infection.
    Pérez-Santiago J; Gianella S; Massanella M; Spina CA; Karris MY; Var SR; Patel D; Jordan PS; Young JA; Little SJ; Richman DD; Smith DM
    AIDS; 2013 Jul; 27(12):1921-31. PubMed ID: 24180001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for autoantibody-induced CD4 depletion mediated by apoptotic and non-apoptotic mechanisms in HIV-positive long-term surviving haemophilia patients.
    Daniel V; Sadeghi M; Naujokat C; Weimer R; Huth-Kühne A; Zimmermann R; Opelz G
    Clin Exp Immunol; 2004 Jan; 135(1):94-104. PubMed ID: 14678269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination antiretroviral therapy with raltegravir leads to rapid immunologic reconstitution in treatment-naive patients with chronic HIV infection.
    Pallikkuth S; Fischl MA; Pahwa S
    J Infect Dis; 2013 Nov; 208(10):1613-23. PubMed ID: 23922374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.